TY - JOUR
T1 - Current clinical practice in neonatal and paediatric parenteral nutrition in Europe
AU - Sewell, GJ
AU - Kluttgens, BU
AU - Nunn, AJ
PY - 2003
Y1 - 2003
N2 - Objective: To investigate current prescribing, compounding, and administration practice of parenteral nutrition (PN) in five European countries, and to explore the use of pre-prepared batch-manufactured standard solutions.
Methods: Questionnaire survey in 218 hospitals in Germany, France, Italy, Spain, and the UK.
Results: 98 hospitals (45%) responded to the questionnaire. Compounding practice was found to differ greatly throughout Europe. Pharmacy aseptic compounding services were usually available in Spain (64%) and the UK (87%), but less often in Germany (35%), France (40%), and Italy (50%). Pre-prepared standard parenteral nutrition solutions were used in 25% of all hospitals surveyed for neonates, and in 17% of hospitals for children. Most of the neonatal standard solutions were prepared within the hospital, whereas commercial contractors supplied standard solutions for children.
Conclusions: We found considerable differences in compounding practice in the five European countries included in the survey. Several hospitals used internally developed standard parenteral nutrition solutions. More international guidance is needed on some of the controversial issues of parenteral nutrition treatment in neonates and children, for example light protection of PN solutions during the administration process and the route of lipid emulsion administration. Also, the safety and efficacy of standard solutions requires further investigation.
AB - Objective: To investigate current prescribing, compounding, and administration practice of parenteral nutrition (PN) in five European countries, and to explore the use of pre-prepared batch-manufactured standard solutions.
Methods: Questionnaire survey in 218 hospitals in Germany, France, Italy, Spain, and the UK.
Results: 98 hospitals (45%) responded to the questionnaire. Compounding practice was found to differ greatly throughout Europe. Pharmacy aseptic compounding services were usually available in Spain (64%) and the UK (87%), but less often in Germany (35%), France (40%), and Italy (50%). Pre-prepared standard parenteral nutrition solutions were used in 25% of all hospitals surveyed for neonates, and in 17% of hospitals for children. Most of the neonatal standard solutions were prepared within the hospital, whereas commercial contractors supplied standard solutions for children.
Conclusions: We found considerable differences in compounding practice in the five European countries included in the survey. Several hospitals used internally developed standard parenteral nutrition solutions. More international guidance is needed on some of the controversial issues of parenteral nutrition treatment in neonates and children, for example light protection of PN solutions during the administration process and the route of lipid emulsion administration. Also, the safety and efficacy of standard solutions requires further investigation.
UR - https://pearl.plymouth.ac.uk/context/hp-research/article/1128/viewcontent/2003_20Current_20clinical_20practice_20in_20neonatal_20and_20paediatric_20parenteral_20nutrition_20in_20Europe_20European_20Journal_20of_20Hospital_20Pharmacy_20_2003__209_20p122_126.pdf
M3 - Article
SN - 2047-9956
VL - 9
SP - 122
EP - 126
JO - European Journal of Hospital Pharmacy
JF - European Journal of Hospital Pharmacy
IS - 0
ER -